Skip to main navigation Skip to search Skip to main content

A Phase 2/3, Multicenter, Open-label, Multicohort, Two-Part Study Evaluating Pharmacokinetics (PK), Safety, and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobiscistat-boosted Darunavir (DRV/co), Administered with a Background...

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date11/13/13 → 11/12/21

Funding

  • Gilead Sciences Incorporated: $13,600.00